Vista, CA, United States of America

Frieder Hofmann

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nono Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frieder Hofmann. Retrieved from https://idiyas.com/inventor/frieder-hofmann-v4x2o9wz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Frieder Hofmann in Neurological Treatments

Introduction: Frieder Hofmann is an accomplished inventor based in Vista, California, known for his contributions to the field of neurological treatments. With a focus on medical formulations, Hofmann has made significant strides in developing innovative solutions aimed at improving patient outcomes in critical situations.

Latest Patents: Hofmann holds a patent for a lyophilized formulation of TAT-NR2B9C with acetylation scavenger. This innovative invention provides stable lyophilized formulations of active agents, specifically TAT-NR2B9c, which includes histidine, trehalose, and lysine. Notably, TAT-NR2B9c has demonstrated potential for treating conditions such as stroke, aneurysm, subarachnoid hemorrhage, and various neurological or neurotraumatic disorders. The formulation's stability at ambient temperature enhances its viability for use in ambulances, enabling timely administration both at the scene of an accident or illness and during transport to medical facilities.

Career Highlights: Hofmann is affiliated with Nono Inc., where he utilizes his expertise to push the boundaries of medical innovation. His focus on lyophilized formulations showcases his commitment to improving medical responses and treatment accessibility during emergencies.

Collaborations: Throughout his career, Frieder Hofmann has collaborated with notable professionals, including Jonathan David Garman. Together, they have worked on projects that enhance the effectiveness of treatments for severe neurological conditions, reflecting a shared dedication to advancing medical science.

Conclusion: Frieder Hofmann's innovative work in developing lyophilized formulations marks a significant advancement in neurological treatment. His commitment to improving patient care through reliable medical solutions underscores the importance of innovation in healthcare. As a talented inventor, Hofmann continues to pave the way for future breakthroughs in medical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…